HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Anna Lassia Meyer Axel Haverich Martin Strüber Permission Requests Google Scholar Articles by Meyer, A. L. Articles by Strüber, M. PubMed Articles by Meyer, A. L. Articles by Strüber, M. Related Collections Mechanical Circulatory Assistance

---

Case Reports

HeartMate II Implantation in Patients With Heparin-Induced Thrombocytopenia Type II

^a Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany
^b Department of Anesthesia, Hannover Medical School, Hannover, Germany
^c Department of Nephrology, Hannover Medical School, Hannover, Germany

Accepted for publication December 29, 2008.

^_* Address correspondence to Dr Strüber, Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany (Email: strueber.martin{at}mh-hannover.de).

Diverse anticoagulation protocols are used in patients after implantation of ventricular assist devices. No consensus exists, especially in patients with heparin-induced thrombocytopenia type II. In a patient with heparin-induced thrombocytopenia type II, we implanted a left ventricular assist device (HeartMate XVE; Thoratec, Pleasanton, CA). Thirteen months later the device had to be replaced due to mechanical failure with a HeartMate II left ventricular assist device. We report on our successful protocol of perioperative anticoagulation management using heparin and iloprost during surgery and argatroban thereafter.